This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Oct 1;58(2):e37; author reply e37-8.

doi: 10.1097/QAI.0b013e31822b4ef2.

Is the study power enough to say "no difference"?

Guilherme Geib, Márcio Debiasi, Nemora T Barcellos, Fernando H Wolff

PMID: 21921724
DOI: 10.1097/QAI.0b013e31822b4ef2

Comment

Is the study power enough to say "no difference"?

Guilherme Geib et al. J Acquir Immune Defic Syndr. 2011.

. 2011 Oct 1;58(2):e37; author reply e37-8.

doi: 10.1097/QAI.0b013e31822b4ef2.

Authors

Guilherme Geib, Márcio Debiasi, Nemora T Barcellos, Fernando H Wolff

PMID: 21921724
DOI: 10.1097/QAI.0b013e31822b4ef2

No abstract available

PubMed Disclaimer

Comment on

HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
Rallón NI, Soriano V, Restrepo C, García-Samaniego J, Labarga P, López M, Peris A, González-Lahoz J, Benito JM. Rallón NI, et al. J Acquir Immune Defic Syndr. 2011 May 1;57(1):1-8. doi: 10.1097/qai.0b013e31821024e7. J Acquir Immune Defic Syndr. 2011. PMID: 21786458

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- MedlinePlus Health Information